Objectives: Commercially available cochlear implant systems attempt to deliver frequency information going down to a few hundred Hertz, but the electrode arrays are not designed to reach the most apical regions of the cochlea, which correspond to these low frequencies. This may cause a mismatch between the frequencies presented by a cochlear implant electrode array and the frequencies represented at the corresponding location in a normal-hearing cochlea. In the following study, the mismatch between the frequency presented at a given cochlear angle and the frequency expected by an acoustic hearing ear at the corresponding angle is examined for the cochlear implant systems that are most commonly used in the United States.
INTRODUCTION
Cochlear implants (CIs) depend on the tonotopic organization of the cochlea to provide frequency information. CIs have arrays of electrodes inserted into the cochlea. With typical CI sound coding, each electrode on the array is assigned a frequency range in an attempt to mimic the tonotopicity of the normal auditory system. Low acoustic frequencies are presented on the more deeply inserted electrodes and therefore sound lower in pitch to a CI user than high acoustic frequencies, which are presented on the more basal electrodes. The default center frequencies for the most apical and basal electrodes vary across CI manufacturers (242 Hz and 7421 Hz for Cochlear, 322 Hz and 6346 Hz for Advanced Bionics, and 149 Hz and 7412 Hz for MED-EL FSP/FS4 strategies). However, because none of the commercially available electrode arrays are designed to reach the most apical regions of the cochlea, there is likely to be a mismatch between the cochlear location stimulated by an implant in response to a given frequency and the location stimulated by the same frequency in a normal cochlea. This may not be an issue for prelingually deaf CI users who develop speech perception based exclusively on input provided by the implant. However, frequency mismatch may be a problem for CI users who learned to understand speech based on the normal frequency-to-place function, then lost their hearing, and after receiving an implant have to adapt to a new and potentially different frequency-to-place function. A function to estimate the frequency that is represented at a given basilar membrane location by a normal ear has been developed by Greenwood (1961) and further modified by Stakhovskya et al. (2007) to account for spiral ganglion neuron location, which is considered the most likely site for CI stimulation.
The ramifications of the place pitch mismatch provided by a CI are unclear. With CI experience, the auditory system adapts such that the pitch associated with a given electrode location shifts toward the frequency information provided by the CI at that location (Svirsky et al. 2004; Reiss et al. 2007 Reiss et al. , 2014 . Similarly, sound quality with a CI also shifts with time. Patients often describe the sound quality of speech as high pitched, robotic, and "Donald Duck"-like when first activated. Numerous anecdotal reports indicate that after experience with the implant, the sound quality from the implant becomes "normal" or at least more normal. These longitudinal changes are accompanied by improvements in speech perception. Although it is widely accepted that most improvement in speech perception performance is seen in the first 3 to 6 months of implant use for postlingual CI recipients, in some cases it might take months or even years to reach asymptotic levels (e.g., Tyler et al. 1997; Svirsky et al. 2001; Hamzavi et al. 2003; Ruffin et al. 2007; Holden et al. 2013) . CI simulations have shown that in acute situations (i.e., with no opportunity for plasticity), listeners can generally tolerate a ±3 mm shift in place of stimulation with only small decrements in speech perception (Fu & Shannon 1999; Li & Fu 2010) , suggesting that proper place pitch matches might not be critical for basic speech understanding. Nevertheless, deviations from the natural frequency locations might limit performance, increase the amount of time postactivation for a CI e208 LANDSBERGER ET AL. / EAR & HEARING, VOL. 36, NO. 5, user to reach asymptote performance, and reduce sound quality (Hochmair et al. 2003; Başkent & Shannon 2003 Fitzgerald et al. 2008; Buchman et al. 2014) . For example, recent data (Buchman et al. 2014) suggest that users of a 31-mm electrode array (MED-EL Standard) perform better and reach asymptotic performance faster than users of a 24-mm electrode array (M), although this small study failed to reach significance (p = 0.07). The ideal electrode length, insertion depth, and frequency allocation are still under discussion in the literature, and it is at least possible that a single setting of all these design parameters may not be ideal for all listeners. In any case, it seems clear that electrode length, position, and the frequencies assigned to each electrode contact have a significant influence on speech perception, sound quality, and ease of adaptation to the CI.
In the present article, we examined the placement of multiple different CI electrode arrays from the patient population at the New York University Cochlear Implant Center. Specifically, we measured the range (in degrees) between the most apical and the most basal electrodes in the array from X-rays. In addition, for each electrode location, we compared the default frequency assigned to the location with the frequency predicted to be represented in the cochlea by a normal acoustic ear according to the spiral ganglion place-frequency map derived by Stakhovskaya et al. (2007) . The following data provide insight into the cochlear range represented by four different electrode arrays, as well as the potential frequency mismatches typically presented to a CI user.
METHODS

Subjects
X-rays for 92 ears with CIs from the New York University Cochlear Implant Center were examined. Thirteen ears were implanted with the MED-EL Standard electrode array, five ears were implanted with the MED-EL Flex28 electrode array, 30 ears were implanted with the Advanced Bionics HiFocus 1J electrode array, and 44 ears were implanted with the Cochlear Nucleus Contour Advance electrode array.
Surgical Technique
A single surgeon implanted 75% of the electrode arrays, and two surgeons implanted 89% of them. All surgeries were performed using the standard transmastoid, transfacial recess (posterior tympanotomy) approach to the cochlea. A periround window (RW) cochleostomy was used for access. This is accomplished by carefully drilling away bone just inferior to the RW approaching the floor of the scala tympani. Once the endosteum is encountered, it is carefully opened without suctioning the perilymph. In some cases, 50% dilute glycerin solution is applied over the cochleostomy so that blood and bone dust floats away from the cochleostomy site. The endosteum is carefully opened, and the electrode is inserted to its distal mark. The electrode is then advanced (off the stylet in the case of Advanced Bionics 1J and Cochlear Contour Advance electrodes) either with the insertion tool supplied by the manufacturer or with a manual technique until a full insertion is obtained. Full insertion is determined by the insertional (proximal) stop point on the electrode lead. The tool and/or stylet are disengaged. The cochleostomy is then sealed using previously harvested small strips of periosteum. Intraoperative impedances and electrically evoked compound action potentials confirm a functional device.
An intraoperative plain X-ray is taken using a transorbital view for simultaneous bilateral implants and an anti-Stenver's view (head tilted at 30 to 45 degrees away from the operated side-see Fig. 1 ) for unilateral implants. The X-ray beam is directed perpendicular to the plane of the operating table, which is leveled before obtaining the image. The image is obtained to verify intracochlear placement and rule out tip rollover or electrode kinks that could be corrected before awakening the patient from general anesthesia. A digital copy of the film is saved in the patient record. A study of 288 surgeries using Nucleus CIs done at our institution (Cosetti et al. 2012) showed five instances of LANDSBERGER ET AL. / EAR & HEARING, VOL. 36, NO. 5, e207-e213 e209 tip rollover or extracochlear electrode placement, which were all corrected after being detected in the intraoperative X-ray.
Measurement of Angular Depth of Insertion
RESULTS
The insertion angle location of all electrodes for 92 cochlear implantations was calculated. The mean insertion angles for the most apical electrode for each of the four electrode array models are presented in Table 1 alongside insertion angle for the most apical electrode results from other studies. In the left panel of Figure 3 , the insertion range for each ear (defined as the range in insertion angle from the most apical to the most basal electrode) is plotted in order of the position of the most apical electrode. A fair amount of variability of insertion angles both within and across electrode array types is observed. In the right panel of Figure 3 , the mean insertion ranges for each electrode type are plotted. A Kruskal-Wallis one-way analysis of variance on ranks (H 3 = 37.214, p < 0.001) detected a significant difference between the insertion ranges across electrode arrays. Post hoc pairwise comparisons (Dunn method) reveal significant differences between the MED-EL Standard array and the Advanced Bionics HiFocus 1J and Nucleus Contour Advance arrays. Similarly, significant differences between the MED-EL Flex28 and the HiFocus 1J and Contour Advance arrays were observed. However, no differences were detected in the insertion range between the HiFocus 1J and the Contour Advance arrays or between the MED-EL Standard and the Flex28 arrays. A similar analysis reveals differences in the positions of the most apical electrodes in the array (H 3 = 28.713, p < 0.001). Post hoc pairwise comparisons reveal significant differences in the apical-most position between the MED-EL Standard array and both the Advanced Bionics HiFocus 1J and the Nucleus Contour Advance electrode arrays, as well as significant difference between the Flex28 and the Contour Advance arrays. A Kruskal-Wallis one-way analysis of variance on ranks (H 3 = 21.960, p < 0.001) reveals a significant difference between the basal location of the different arrays. Post hoc pairwise comparisons reveal that the HiFocus 1J basal position is significantly different than all other arrays in the basal location. The variability in the HiFocus 1J insertion could potentially be explained by the lack of a fixed insertional stop point, which may result in more variable insertion angle.
The mean locations for each electrode on each electrode array are plotted in Figure 4 as a function of the center frequency of the filter corresponding to the electrode position from the default frequency allocation table. In addition, the place-frequency map for neurons in the spiral ganglion (Stakhovskaya et al. 2007 ) is plotted in green. For frequencies above approximately 650 Hz, the place-frequency functions & HEARING, VOL. 36, NO. 5, are similar for all devices. However, substantial deviations in the place-frequency functions are observed for frequencies below approximately 650 Hz. Figure 5 shows that the default frequencies provided by all four electrode arrays are approximately an octave below the predicted spiral ganglion pitch for insertions up to approximately 270°. Beyond 270°, the deviation between the default frequency and the predicted SG pitch is varied across electrode arrays. Similarly, for insertion angles below approximately 270°, a deeper insertion of approximately 90° would provide an accurate default frequency allocation to represent the predicted SG pitch for the corresponding location for all electrode arrays. However, for electrodes located beyond 270°, the deeper insertion required to maintain the SG pitch estimate increases and becomes more variable across electrode arrays.
DISCUSSION
Clearly, there are important similarities, as well as differences, among electrode location data for the four different types of electrodes, and between all electrode types and the spiral ganglion frequency versus angle of insertion function. One difference is that the MED-EL Standard and Flex28 electrode arrays are longer and achieve a deeper insertion angle than the HiFocus 1J and the Contour Advance arrays. The MED-EL Standard and Flex28 measure 31 and 28 mm in length, while the HiFocus 1J and the Contour Advance are 25 and 24 mm in length, respectively. Another significant point is that all four electrode arrays, when combined with the corresponding default frequency-to-electrode tables, result in a frequency shift of about one octave (12 semitones) with respect to the place-frequency map in the spiral (Table 1) . This type of frequency shift can be minimized in at least three ways: by using electrode arrays that reach a deeper insertion angle, by using different frequency-to-electrode tables, or by letting patients adjust to the new frequency-place map hoping that auditory plasticity will compensate for the frequency shift. Deeper insertion angles would move data points in Figure 4 upward, getting closer to the spiral ganglion map curve. Changing the frequency-to-electrode table to higher values would move points in Figure 4 from left to right, achieving the same result. Last, auditory plasticity would change the spiral ganglion map in the direction of the frequency table used by the patient over the long term. Each approach has potential advantages and disadvantages. There is a possible trade-off between deeper insertion and additional cochlear trauma, which may be particularly important in cases where the implanted ear has usable residual hearing. In addition, a deep insertion angle likely should not be sought at the expense of basal stimulation as it reduces speech performance outcomes in that case (e.g., Hochmair et al. 2003; Finley et al. 2008; Sydlowski et al. 2010; Holden et al. 2013) . It is worth noting that the surgical point of insertion (i.e., via cochleostomy or RW) will also affect the insertion depth of the electrode array. The second approach, changing the frequency-to-electrode table, can easily be done even in cases of very shallow electrode insertions. The disadvantage of altering the frequency-to-electrode table is that typically adjusting the frequency allocations to match the spiral ganglion map would require reducing the range of frequencies represented by the frequency allocation tables. The last approach is the one that seems to have been adopted by the consensus of CI designers: rely on the human brain's ability to adapt to a modified peripheral mapping. There is a substantial body of work suggesting that humans can indeed show remarkable amounts of auditory adaptation. The first downside is that even though the bulk of this adaptation process takes place within the first few months after implantation, it can sometimes take additional months or years for the process to be complete, and there are also some indications that at least for some listeners the process is not always complete even after extensive experience (Svirsky et al. 2004; Sagi et al. 2010; Reiss et al. 2014) .
The MED-EL Standard and Flex28 arrays cover a greater range of the cochlea than the Contour Advance or 1J electrodes, and this allows the MED-EL frequency-to-electrode table to reach down to 100 Hz without a significant departure from the spiral ganglion map curve. In fact, below 650 Hz the curves for the MED-EL arrays are somewhat closer to the spiral ganglion map curve than the other two arrays.
It is worth noting that a correct place pitch match may not be important to achieve. For example, Gani et al. (2007) and Arnoldner et al. (2007) showed that disabling a subset of electrodes near the apex of MED-EL Standard arrays yielded improved performance. By disabling electrodes near the apex, the frequency allocation was shifted away from the spiral ganglion map, suggesting that optimal performance might be obtained for place-frequency allocations away from the spiral ganglion map. Another potential reason for this benefit is that spread of excitation (and therefore channel interaction) might be greater in the apex (Kalkman et al. 2014) . If so, apical stimulation would be less precise than stimulation in the middle and basal regions, reducing the need for an accurate frequency-place match. This possibility is supported by the findings that with 31-mm electrodes, some users are able to get good pitch information from all electrodes while others have difficulty discriminating the most apical electrodes (Baumann & Nobbe 2006; Hamzavi & Arnoldner 2006; Gani et al. 2007; Landsberger et al. 2014) . Alternatively, an accurate frequency place match might require a current focused stimulation mode (e.g., Landsberger et al. 2012; Fielden et al. 2013; Saoji et al. 2013) in the apex to obtain proper place specificity. Further studies are required to fully assess the clinical significance of the frequency mismatch.
The question arises whether the frequency estimate from Stakhovskaya et al. (2007) is indeed the most relevant place & HEARING, VOL. 36, NO. 5, pitch map for analyzing CI stimulation. One way to address the validity of that frequency-to-place map would be to examine electroacoustic pitch matching studies performed very shortly after initial stimulation, preferably before users have had any experience listening to speech with their implant. Vermeire et al. (2011) pitch matched single electrode pulse trains in one ear to acoustic pure-tones in a normal-hearing contralateral ear with subjects before they had any opportunity to adapt to a speech-processing strategy. Although pitch matches were not significantly different from the spiral ganglion estimate, responses tended to be lower in frequency than predicted by the spiral ganglion map. A similar result was obtained by McDermott et al. (2009) , who examined pitch matches on the most apical electrode of Nucleus users who completed the experiment before experiencing any other sounds through their CI.
Results from three of five subjects were consistent with the Stakhovskaya et al. map, whereas results for the two other subjects were somewhat lower in frequency than would be predicted by the map. In summary, behavioral data suggest that the Stakhovskaya et al. map may not be perfect but it might be a reasonable first approximation, thus justifying its use in the present analyses.
The present results, together with the existing literature on speech perception by postlingually deafened CI users, suggest that standard placement and programming of most CIs result in a certain amount of frequency mismatch with respect to normal acoustic stimulation of the cochlea. The same literature, however, suggests that the human brain is quite capable of adapting to better deal with such frequency mismatch, at least to some extent. Here, we quantified the approximate intracochlear location of different electrodes and examined it in reference to the default frequency allocation tables used by the corresponding speech processors, and later compared the resulting curves to a reasonable estimate of an acoustic frequency-to-place map in the human cochlea. Perhaps the most remarkable feature of this data set lies in the similarities across manufacturers rather than in the differences. Consider that Figure 4 results from the independent efforts of different electrode design teams (which largely determine positions of the data points along the y axis) and different signal processing teams (which largely determine positions along the x axis) at three different companies, and yet the curves show a remarkable degree of overlap above 650 Hz.
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